JP2015515971A - うつ病を治療するためのトラマドール - Google Patents

うつ病を治療するためのトラマドール Download PDF

Info

Publication number
JP2015515971A
JP2015515971A JP2015509478A JP2015509478A JP2015515971A JP 2015515971 A JP2015515971 A JP 2015515971A JP 2015509478 A JP2015509478 A JP 2015509478A JP 2015509478 A JP2015509478 A JP 2015509478A JP 2015515971 A JP2015515971 A JP 2015515971A
Authority
JP
Japan
Prior art keywords
tramadol
salt
pharmaceutical composition
depression
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015509478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015515971A5 (enExample
Inventor
ヤング，マルコム・フィリップ
マキューン，フィリップ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics PLC filed Critical E Therapeutics PLC
Publication of JP2015515971A publication Critical patent/JP2015515971A/ja
Publication of JP2015515971A5 publication Critical patent/JP2015515971A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015509478A 2012-05-04 2013-05-03 うつ病を治療するためのトラマドール Pending JP2015515971A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1207907.5 2012-05-04
GBGB1207907.5A GB201207907D0 (en) 2012-05-04 2012-05-04 Treatment of depression
PCT/GB2013/000197 WO2013164561A1 (en) 2012-05-04 2013-05-03 Tramadol for treating depression

Publications (2)

Publication Number Publication Date
JP2015515971A true JP2015515971A (ja) 2015-06-04
JP2015515971A5 JP2015515971A5 (enExample) 2016-06-23

Family

ID=46396577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509478A Pending JP2015515971A (ja) 2012-05-04 2013-05-03 うつ病を治療するためのトラマドール

Country Status (8)

Country Link
US (1) US20150093438A1 (enExample)
EP (1) EP2846786A1 (enExample)
JP (1) JP2015515971A (enExample)
AU (1) AU2013255668A1 (enExample)
CA (1) CA2871171A1 (enExample)
GB (1) GB201207907D0 (enExample)
WO (1) WO2013164561A1 (enExample)
ZA (1) ZA201408849B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525241A (ja) * 2000-03-01 2003-08-26 ユーロセルティック ソシエテ アノニム 機能性胃腸疾患治療用トラマドール
JP2009536927A (ja) * 2006-05-12 2009-10-22 オディディ，イサ 乱用可能性が低減された医薬組成物
JP2010530867A (ja) * 2007-06-22 2010-09-16 イー セラピューティクス ピー エル シー うつ病の治療

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
DE10015479A1 (de) 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1905435A3 (en) * 2003-03-11 2008-05-14 Euro-Celtique S.A. Titration dosing regimen for controlled release tramadol
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
GB0811024D0 (en) * 2008-06-17 2008-07-23 E Therapeutics Plc Sustained release treatment of depression
US20130296437A1 (en) * 2012-05-04 2013-11-07 E-Therapeutics Plc Treatment of Depression

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525241A (ja) * 2000-03-01 2003-08-26 ユーロセルティック ソシエテ アノニム 機能性胃腸疾患治療用トラマドール
JP2009536927A (ja) * 2006-05-12 2009-10-22 オディディ，イサ 乱用可能性が低減された医薬組成物
JP2010530867A (ja) * 2007-06-22 2010-09-16 イー セラピューティクス ピー エル シー うつ病の治療

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FANELLI JOSEPH: "USE OF THE ANALGESIC TRAMADOL IN ANTIDEPRESSANT POTENTIATION", PSYCHOPHARMACOLOGY BULLETIN, vol. V32, JPN5015006508, 1 January 1998 (1998-01-01), US, pages 442, ISSN: 0003513106 *

Also Published As

Publication number Publication date
AU2013255668A1 (en) 2014-12-04
EP2846786A1 (en) 2015-03-18
US20150093438A1 (en) 2015-04-02
ZA201408849B (en) 2015-12-23
WO2013164561A1 (en) 2013-11-07
GB201207907D0 (en) 2012-06-20
CA2871171A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
KR101890450B1 (ko) Ｃｎｓ 장애의 치료에 사용되는 브렉스피프라졸 또는 이의 염 및 2 차 약물을 포함하는 조합물
JP4758064B2 (ja) 有効物質を徐放する３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）フェノール含有医薬
US20110212173A1 (en) Controlled Release Treatment of Depression
JP7269227B2 (ja) ニラパリブ処方物
KR101607112B1 (ko) 타펜타돌 조성물
JP6109127B2 (ja) 薬学的組成物
US20090023744A1 (en) Combination therapy for depression
US7569612B1 (en) Methods of use of fenofibric acid
US20150250733A1 (en) Oral drug delivery formulations
JP2017222679A (ja) 医薬組成物
KR101858797B1 (ko) 히드로모르폰 및 날록손을 포함하는 제약 조성물
KR102851614B1 (ko) 장애 치료를 위한 중수소화된 돔페리돈 조성물 및 방법
KR20180132141A (ko) 변형된 방출 남용 억제 투약 형태
CN106456550A (zh) 避免乙醇剂量倾泻的多颗粒
EA021321B1 (ru) Новые композиции 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
US20130296437A1 (en) Treatment of Depression
WO2006119389A2 (en) Quinine-containing controlled-release formulations
JP2009535409A (ja) 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
JP2015515971A (ja) うつ病を治療するためのトラマドール
US20080058345A1 (en) Combination Therapy with Mecamylamine for the Treatment of Mood Disorders
HK1191234B (en) Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
HK1191234A (en) Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160502

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170307

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180213